• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO; CORONARY DRUG ELUDING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO; CORONARY DRUG ELUDING STENT Back to Search Results
Catalog Number SEE MODEL NO.
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 08/02/2022
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.Only the product name (i.E.No size, no lot, no ref) and an event description were provided.The date of the initial procedure was not reported.The complaint instrument was not returned.Images of the case such as angiographies or ivus records could also not be obtained.Therefore, no complaint investigation could be performed.The additional information provided by the hospital (stent thrombosis case report) was not sufficient to establish whether a device deficiency could be the cause for this event.According to the stent thrombosis case report, only one antiplatelet drug was used but this was unrelated to the development of the very late stent thrombosis.Please note that, according to the ifu, administration of appropriate anticoagulant, antiplatelet and vasodilatation therapy is critical to successful stent implantation.
 
Event Description
In-stent restenosis in a patient who had orsiro placed 3 years ago.Pci was performed and evaluated by ivus, oct, and endoscopy.The stent was normally covered with the intima, but a thrombus adhered to the stent placement site, and it was judged to be a very late stent thrombosis (vlst).At the time of vlst, only one antiplatelet drug was used, but this is not considered to be the cause.The patients outcome is good and has already been discharged home.No lot number or size was available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO
Type of Device
CORONARY DRUG ELUDING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key15433349
MDR Text Key300024387
Report Number1028232-2022-04757
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility,Company Representative,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/15/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberSEE MODEL NO.
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-